Emmaus Life Sciences Reports Quarterly Financial ResultsAugust 14, 2025
Emmaus Life Sciences, Inc., today reported on its financial condition and results of operations as of and for the three and six months ended June 30, 2025.
Read More
Emmaus Life Sciences, Inc., today reported on its financial condition and results of operations as of and for the three and six months ended June 30, 2025.
Read MoreChanges Based on Additional Pharmacokinetics Data
Read MoreEmmaus Life Sciences, Inc., today reported on its financial condition and results of operations as of and for the three months ended March 31, 2025.
Read MoreEmmaus Life Sciences, Inc., today reported on its financial condition and results of operations as of and for the year ended December 31, 2024.
Read MoreInitial One-Year Exclusivity Period Will Be Extended to Three Years if Endari is Approved for Marketing
Read More